Brief: Haemonetics Corp Q2 Fiscal 2023 Revenue Rises 24%

Haemonetics

07/11/2022 11:14

Nov 7 (Reuters) - Haemonetics Corp  HAE.N :
    * Q2 FISCAL 2023 REVENUE WAS $297.5 MILLION, UP 24.0%
COMPARED
WITH Q2 OF FISCAL 2022
    * QTRLY EARNINGS PER DILUTED SHARE $0.64
    * QTRLY ADJUSTED EARNINGS PER DILUTED SHARE $0.83
    * UPDATED PREVIOUS FISCAL 2023 GAAP TOTAL REVENUE GROWTH
GUIDANCE
FROM 8 - 11% TO 12 - 15%
    * SEES FISCAL 2023 ADJUSTED EARNINGS PER DILUTED SHARE $2.70
-
$3.00
    * Q2 EARNINGS PER SHARE VIEW $0.67, REVENUE VIEW $269.2
MILLION --
REFINITIV IBES DATA
    * FY2023 EARNINGS PER SHARE VIEW $2.79, REVENUE VIEW $1.09
BILLION
-- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn9YwLfPa 
Further company coverage:  HAE.N 
 ((Reuters.Briefs@thomsonreuters.com;))